[1]
H. M. Y. Rehman, A. L. Khattak, T. A. Khan, A. M. Tariq, S. A. Satti, and R. U. Din, “LIPID-LOWERING EFFICACY OF 20 MG SIMVASTATIN VERSUS 5 MG ROSUVASTATIN IN PATIENTS OF TYPE 2 DIABETES”, Pak Armed Forces Med J, vol. 70, no. 4, pp. 885–89, Aug. 2020, Accessed: Nov. 22, 2024. [Online]. Available: https://pafmj.org/PAFMJ/article/view/5050